Medicine Description sifrol 0.7mg
Sifrol 0.7 mg 30 tablets is a medication primarily used to manage symptoms of Parkinson's disease and Restless Legs Syndrome (RLS). Its active ingredient, pramipexole, is a selective agonist of dopamine D2 and D3 receptors. By binding to these receptors in the brain, pramipexole mimics the action of dopamine, a neurotransmitter critical for regulating movement and coordination. The deficiency of dopamine in the brain contributes to the motor symptoms observed in Parkinson's disease. By stimulating these receptors, Sifrol helps alleviate symptoms such as tremors, stiffness, and bradykinesia (slowness of movement). The mechanism also extends to enhancing the patient's capacity for voluntary movement and decreasing the physical discomfort associated with RLS, thus improving overall quality of life.
Indications and Uses of Sifrol 0.7 mg 30 tablets
- Treatment of Parkinson's disease
- Management of Restless Legs Syndrome (RLS)
Side Effects of Sifrol 0.7 mg 30 tablets
- Nausea
- Dizziness
- Somnolence
- Orthostatic hypotension
- Hallucinations
- Constipation
- Fatigue
Storage and Handling
Store at room temperature, away from moisture and heat. Keep out of reach of children and avoid exposure to light.
Patient Advice and Precautions
Patients should be informed to report any unusual changes in mood or behavior, as well as any persistent side effects. It is essential to avoid sudden discontinuation without consulting a healthcare provider, as this may lead to withdrawal symptoms. Regular follow-ups with a healthcare professional are necessary to monitor the effectiveness and any potential side effects of the treatment.